dc.contributor.author
Junyent Herena, Fèlix
dc.contributor.author
Verdaguer Cardona, Ester
dc.contributor.author
Folch, Jaume
dc.contributor.author
Beas Zárate, Carlos
dc.contributor.author
Pallàs i Llibería, Mercè, 1964-
dc.contributor.author
Auladell i Costa, M. Carme
dc.contributor.author
Camins Espuny, Antoni
dc.date.issued
2012-10-04T10:37:46Z
dc.date.issued
2012-10-04T10:37:46Z
dc.identifier
https://hdl.handle.net/2445/32186
dc.description.abstract
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/32393
dc.description.abstract
The c-Jun N-terminal kinases (JNK) are members of the MAPK family and can be activated by different stimuli such as cellular stress, heat shock and ultra-violet irradiation. JNKs have different physiological functions and they have been linked to apoptosis in different cell types. Therefore, the JNK signalling pathway is an important target to prevent cell death. In the present chapter, the role of JNKs in neurodegenerative diseases will be discussed, as well as the pharmacological compounds that inhibit this signalling pathway as therapeutic intervention to prevent neuronal death.
dc.format
application/pdf
dc.publisher
Transworld Research Network
dc.relation
Reproducció del capítol 2 del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=131
dc.relation
Recent Advances in Pharmaceutical Sciences II, 2012, Editor: Diego Muñoz-Torrero, Diego Haro and Joan Vallès, Chapter 2, p. 15-28.
dc.relation
http://hdl.handle.net/2445/32393
dc.rights
(c) Transworld Research Network, 2012
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Llibres / Capítols de llibre (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject
Malalties neurodegeneratives
dc.subject
Neurodegenerative Diseases
dc.title
Role of JNK in neurodegenerative diseases
dc.type
info:eu-repo/semantics/bookPart
dc.type
info:eu-repo/semantics/publishedVersion
